204 related articles for article (PubMed ID: 18172943)
1. [Resistance and refractoriness in obsessive-compulsive disorder].
Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E
Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943
[TBL] [Abstract][Full Text] [Related]
2. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
[No Abstract] [Full Text] [Related]
3. Psychosocial treatment for obsessive-compulsive disorder.
Munford PR; Hand I; Liberman RP
Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of obsessive-compulsive disorder: a review for clinicians.
McDonough M; Kennedy N
Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928
[TBL] [Abstract][Full Text] [Related]
7. Drug treatment of obsessive-compulsive disorder.
Kellner M
Dialogues Clin Neurosci; 2010; 12(2):187-97. PubMed ID: 20623923
[TBL] [Abstract][Full Text] [Related]
8. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
Jenike MA; Rauch SL
J Clin Psychiatry; 1994 Mar; 55 Suppl():11-7. PubMed ID: 7915709
[TBL] [Abstract][Full Text] [Related]
9. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.
Walsh KH; McDougle CJ
Expert Opin Pharmacother; 2004 Oct; 5(10):2059-67. PubMed ID: 15461541
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
Dold M; Aigner M; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614
[TBL] [Abstract][Full Text] [Related]
13. Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
Metin O; Yazici K; Tot S; Yazici AE
Hum Psychopharmacol; 2003 Aug; 18(6):463-7. PubMed ID: 12923825
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].
Dold M; Aigner M; Lanzenberger R; Kasper S
Fortschr Neurol Psychiatr; 2011 Aug; 79(8):453-66. PubMed ID: 21809258
[TBL] [Abstract][Full Text] [Related]
15. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
Prazeres AM; Souza WF; Fontenelle LF
Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of obsessive-compulsive disorder in an adult].
Kähkönen S; Holmberg N
Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
[TBL] [Abstract][Full Text] [Related]
17. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
[TBL] [Abstract][Full Text] [Related]
18. Current issues in the pharmacologic management of obsessive compulsive disorder.
Rasmussen SA; Eisen JL; Pato MT
J Clin Psychiatry; 1993 Jun; 54 Suppl():4-9. PubMed ID: 8101187
[TBL] [Abstract][Full Text] [Related]
19. Obsessive compulsive disorder.
Soomro GM
Clin Evid; 2003 Dec; (10):1172-87. PubMed ID: 15555141
[No Abstract] [Full Text] [Related]
20. Pharmacological management of treatment-resistant obsessive-compulsive disorder.
Abudy A; Juven-Wetzler A; Zohar J
CNS Drugs; 2011 Jul; 25(7):585-96. PubMed ID: 21699270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
